Google
EVGN — EVOGENE (Healthcare >> Biotechnology)
EVGN FAQ
What is EVGN's P/E ratio?
EVOGENE (EVGN) currently trades at a P/E ratio of 1.66.
What is EVGN's ROE?
EVOGENE reports a Return on Equity (ROE) of 462.36%.
What is EVGN's dividend yield?
EVOGENE offers a dividend yield of 0.00%.
What is EVGN's Deepscope Quality Score?
Deepscope rates EVGN's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy EVGN?
Deepscope's AI Timing Score for EVGN is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does EVGN belong to?
EVOGENE is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 0.62
Price
0.01
(1.53%)
Day Change
|
|
|---|
EVGN, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
57% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 74 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.62 |
| PBV / Sector |
0.58 / 4.63
GREAT
|
| Earning Per Share | -1.13 |
| PE / Sector |
1.66 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
-0.04 / 0.53
|
| Average 1M Daily Value |
0.82 M
GREAT
|
| Average 1W Daily Value |
3.15 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
58% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:24 |
| Symbol | EVGN |
| Name | EVOGENE |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 10.41 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 6.45 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 13 Gad Feinstein Street, Rehovot, Israel, 7638517
Phone: 972 8 931 1900
Website: https://www.evogene.com
Employees: 52
Sector: Healthcare >> Biotechnology
Description: Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
